National Vacancy for Professional Officer
Pharmaceutical Defence Limited (PDL) is a member owned organisation supporting around 31,000 pharmacist members and the pharmacy profession. The leading risk advisors to the profession, PDL’s incident support service is dedicated to members around the clock, for confidential, expert advice. The professional indemnity policy for pharmacists provided by PDL covers everything in the scope of […]
Managing high-risk S8, S4B and S4D medicines
PDL NSW members were recently sent a Forum communique on 13 October 2022 regarding the joint initiative between the Pharmacy Council of NSW, NSW Health and the pharmacy organisations representing most NSW pharmacists. As mentioned in the communique, the purpose of the Forum is to: monitor regulatory issues that impact on the governance and performance […]
NSW Pharmacy Quarterly Stakeholder Forum 2022 – Communique
The Pharmacy Council of NSW has launched a new initiative involving a quarterly forum bringing together key pharmacy stakeholder agencies to discuss issues of relevance to the profession. The impetus for this initiative was an increase in complaints about pharmacists to the Health Care Complaints Commission and the Pharmacy Council. The specific purpose of the […]
A conversation with Amanda Galbraith
Our recently retired and newly appointed PDL Directors for the ACT and NSW, Curtis Ruhnau and Amanda Galbraith, sat down to discuss what has been happening in their space. Curtis Ruhnau: G’day Amanda, I remember when you were appointed to the PDL Board as the first female Director for NSW/ACT, and the first Director residing […]
UTIPP-Q pilot transition to EPA
Pharmacists practising in Queensland are advised the UTIPP-Q pilot has finished and the Urinary Tract Infection Community Pharmacy Service is now allowed under the Pharmacists Extended Practice Authority (EPA). Pharmacists and pharmacies can now offer the UTI service according to the provisions of the EPA. The following update from Professor Lisa Nissen on behalf of […]
Notice of Annual General Meeting
Notice is hereby given that the 110th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3, Level 34 North Tower, 80 Collins Street, Melbourne 3000 and online via Microsoft Teams, on Thursday, the 20th of October 2022 at 11:00am AEDT when the attendance of members is […]
UTIPP-Q pilot latest announcement
Pharmacists practising in Queensland are advised that after Friday, 9 September 2022, new pharmacists and pharmacies will no longer be accepted into the UTIPP-Q pilot. The following update from Professor Lisa Nissen on behalf of the consortium managing the pilot provides further context. Thank-you to all the pharmacists and pharmacies who have participated in the […]
Be alert with varicella vaccines
PDL has recently received several incident reports where the incorrect varicella vaccine has been prescribed and/or supplied. Prescribing software programs have variations on how the vaccines are described, potentially leading to confusion for prescribers and pharmacists. Most reports indicate the intended varicella vaccine is for the prevention of chickenpox however transcription and selection errors have […]
Top 10 drugs in PDL incident reports
It is no surprise that the top four drugs on our list are Schedule 8’s (S8s). Dispensing errors can happen with any drug but the top four are also prone to diversion, forgeries and theft. Another reason this group is overrepresented is that some of them are available in immediate release (IR) and sustained release […]
Election of PDL Directors to the National Board
The following vacancies will occur as of the date of the next Annual General Meeting to be held on 20 October 2022 One Director for the State of Victoria One Director for the State of Tasmania The two incumbent Directors whose terms expire at the 2022 Annual General Meeting (Paul Naismith in Victoria and Joe […]
